State of Alaska Department of Revenue lifted its holdings in Chemed Co. (NYSE:CHE – Free Report) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,853 shares of the company’s stock after purchasing an additional 115 shares during the period. State of Alaska Department of Revenue owned about 0.13% of Chemed worth $11,930,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. GAMMA Investing LLC boosted its holdings in Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares during the last quarter. American National Bank & Trust acquired a new stake in Chemed in the 3rd quarter worth about $61,000. EntryPoint Capital LLC boosted its holdings in Chemed by 14.0% in the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after buying an additional 18 shares during the last quarter. Mather Group LLC. boosted its holdings in Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after buying an additional 69 shares during the last quarter. Finally, Quarry LP boosted its holdings in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after buying an additional 166 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.
Chemed Trading Up 1.0 %
CHE stock opened at $602.98 on Monday. Chemed Co. has a 12-month low of $516.03 and a 12-month high of $654.62. The stock has a market cap of $9.13 billion, a price-to-earnings ratio of 32.45, a PEG ratio of 2.44 and a beta of 0.44. The business’s 50-day moving average is $586.25 and its 200 day moving average is $569.41.
Chemed Increases Dividend
Insider Transactions at Chemed
In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the transaction, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the transaction, the executive vice president now directly owns 5,990 shares in the company, valued at $3,363,864.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the transaction, the director now owns 3,446 shares in the company, valued at approximately $1,991,615.70. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 9,144 shares of company stock worth $5,264,839 in the last ninety days. Insiders own 3.32% of the company’s stock.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More
- Five stocks we like better than Chemed
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Where Do I Find 52-Week Highs and Lows?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Are Dividend Contenders? Investing in Dividend Contenders
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.